Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
OBJECTIVE
Previous studies of the association between body mass index (BMI) and colorectal cancer among women found increased risk only among women who were premenopausal or used hormone replacement therapy (HRT). These results led to the hypothesis that BMI may increase risk more strongly among women with higher levels of circulating estrogen. We examined the association between BMI and colorectal cancer incidence by use of HRT, and number of postmenopausal years without HRT, a measure of duration of exposure to lower levels of estrogen.


METHODS
During follow-up from 1992-2003, 814 incident colorectal cancer cases were identified among 73,842 postmenopausal women in the Cancer Prevention Study-II Nutrition Cohort. Information on BMI and other risk factors was obtained from questionnaires completed at enrollment in 1992-1993 and during follow-up. Hazard ratios were calculated using proportional hazards modeling.


RESULTS
The association between BMI and colorectal cancer incidence was similar among never-users of HRT (hazard ratio 1.13, 95% confidence interval 1.02-1.25 per 5-unit increase in BMI) and current-users of HRT (hazard ratio 1.08, 95% confidence interval 0.92-1.27 per 5-unit increase in BMI). Among women not currently using HRT, the association between BMI and colorectal cancer did not differ by postmenopausal years without HRT.


CONCLUSIONS
Our results do not support the hypothesis that BMI increases risk of colorectal cancer more strongly among women with higher levels of estrogen.
Wang
Yiting
Y
Department of Epidemiology and Surveillance Research, American Cancer Society, Clifton Road NE, Atlanta, GA 1599, USA. yiting.wang@cancer.org
Jacobs
Eric J
EJ
Teras
Lauren R
LR
Pavluck
Alexandre L
AL
Rodriguez
Carmen
C
Thun
Michael J
MJ
Calle
Eugenia E
EE
D015992:Body Mass Index; D015331:Cohort Studies; D015179:Colorectal Neoplasms / Q000453:epidemiology*; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D020249:Hormone Replacement Therapy; D006801:Humans; D015994:Incidence; D008593:Menopause; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors
D004967:Estrogens